Chulani Karunatilake

Technik-/Wissenschafts-/F&E-Leiter bei WEREWOLF THERAPEUTICS, INC.

Vermögen: - $ am 31.05.2024

65 Jahre

Health Technology

Consumer Services

Aktive Positionen von Chulani Karunatilake

Unternehmen	Position	Beginn	Ende
WEREWOLF THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	15.06.2021	-

Unternehmen	Position	Beginn	Ende
NEKTAR THERAPEUTICS	Corporate Officer/Principal	-	-
Maverick Therapeutics, Inc. Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA.	Corporate Officer/Principal	-	-

University of Illinois	Doctorate Degree
University of Colombo	Undergraduate Degree

International

Vereinigte Staaten	5
Sri Lanka	2

Operativ

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	1
Doctorate Degree	1

Sektoral

Health Technology	4
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
WEREWOLF THERAPEUTICS, INC.	Health Technology
NEKTAR THERAPEUTICS	Health Technology

Private Unternehmen	1
Maverick Therapeutics, Inc. Maverick Therapeutics, Inc. BiotechnologyHealth Technology Maverick Therapeutics, Inc. operates as a preclinical stage biotech company. It develops a novel class of T cell- redirecting antibody therapeutics that have the potential to substantially broaden the range of targets and clinical applications to be used for this ultra-potent mechanism. The company was founded by Robert Dubridge and Patrick A. Baeuerle in 2016 and is headquartered in Brisbane, CA.	Health Technology

Private Unternehmen

Health Technology